- Home
- VRDN vs OLPX Comparison
VRDN vs OLPX Comparison
Compare VRDN & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- OLPX
- Stock Information
- Founded
- VRDN 2006
- OLPX 2014
- Country
- VRDN United States
- OLPX United States
- Employees
- VRDN N/A
- OLPX N/A
- Industry
- VRDN Medical Specialities
- OLPX Package Goods/Cosmetics
- Sector
- VRDN Health Care
- OLPX Consumer Discretionary
- Exchange
- VRDN Nasdaq
- OLPX Nasdaq
- Market Cap
- VRDN 1.3B
- OLPX 1.0B
- IPO Year
- VRDN N/A
- OLPX 2021
- Fundamental
- Price
- VRDN $17.14
- OLPX $1.50
- Analyst Decision
- VRDN Strong Buy
- OLPX Hold
- Analyst Count
- VRDN 11
- OLPX 4
- Target Price
- VRDN $38.50
- OLPX $1.85
- AVG Volume (30 Days)
- VRDN 707.7K
- OLPX 1.4M
- Earning Date
- VRDN 08-07-2025
- OLPX 08-05-2025
- Dividend Yield
- VRDN N/A
- OLPX N/A
- EPS Growth
- VRDN N/A
- OLPX N/A
- EPS
- VRDN N/A
- OLPX 0.02
- Revenue
- VRDN $302,000.00
- OLPX $420,742,000.00
- Revenue This Year
- VRDN N/A
- OLPX $1.32
- Revenue Next Year
- VRDN $17,102.33
- OLPX $3.12
- P/E Ratio
- VRDN N/A
- OLPX $81.24
- Revenue Growth
- VRDN 4.86
- OLPX N/A
- 52 Week Low
- VRDN $9.90
- OLPX $1.01
- 52 Week High
- VRDN $27.20
- OLPX $2.77
- Technical
- Relative Strength Index (RSI)
- VRDN 71.50
- OLPX 49.47
- Support Level
- VRDN $13.84
- OLPX $1.34
- Resistance Level
- VRDN $17.53
- OLPX $1.59
- Average True Range (ATR)
- VRDN 0.79
- OLPX 0.10
- MACD
- VRDN 0.21
- OLPX -0.01
- Stochastic Oscillator
- VRDN 89.43
- OLPX 33.90
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About OLPX Olaplex Holdings Inc.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.